Results 51 to 60 of about 1,626,261 (197)

Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor

open access: yesThe Journal of Headache and Pain, 2022
Background The clinical use of calcitonin gene-related peptide receptor (CGRP-R) antagonists and monoclonal antibodies against CGRP and CGRP-R has offered new treatment possibilities for migraine patients.
Sanne Hage La Cour   +6 more
doaj   +1 more source

Insight into the role of the gut-brain axis in alcohol-related responses: Emphasis on GLP-1, amylin, and ghrelin

open access: yesFrontiers in Psychiatry, 2023
Alcohol use disorder (AUD) contributes substantially to global morbidity and mortality. Given the heterogenicity of this brain disease, available pharmacological treatments only display efficacy in sub-set of individuals.
Maximilian Tufvesson-Alm   +2 more
doaj   +1 more source

Amylin receptor blockade stimulates food intake in rats [PDF]

open access: yesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
Amylin is postulated to act as a hormonal signal from the pancreas to the brain to inhibit food intake and regulate energy reserves. Amylin potently reduces food intake, body weight, and adiposity when administered systemically or into the brain. Whether selective blockade of endogenous amylin action increases food intake and adiposity remains to be ...
Roger D, Reidelberger   +5 more
openaire   +2 more sources

History of current non-insulin medications for diabetes mellitus [PDF]

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2012
This article is a brief review of the current non-insulin agents for diabetes mellitus in the United States, namely, sulfonylureas, biguanides, thiazolidinediones, meglitinides, α-glucosidase inhibitors, glucacon-like peptide-1 receptor agonists ...
Celeste C. L. Quianzon, Issam E. Cheikh
doaj   +1 more source

Ventral tegmental area amylin / calcitonin receptor signaling suppresses feeding and weight gain in female rats

open access: yesNeuroscience Research
The pancreatic peptide amylin promotes negative energy balance in part through activation of amylin receptors (AmyRs) expressed in the ventral tegmental area (VTA), but studies have been limited to male rodents.
Tyler J. Gustafson   +3 more
doaj   +1 more source

Therapeutic access points: The roles of circumventricular organs in drug delivery and metabolic regulation

open access: yesBritish Journal of Pharmacology, EarlyView.
The current obesity drug landscape, dominated by GLP‐1 receptor agonists and emerging multi‐agonist therapies, has reinforced that long‐term weight loss is achieved in large part through central mechanisms that suppress appetite and reshape energy balance.
Ines Martinez‐Corral   +3 more
wiley   +1 more source

Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo [PDF]

open access: yes, 2004
Amylin is a member of the calcitonin family of hormones cosecreted with insulin by pancreatic ß cells. Cell culture assays suggest that amylin could affect bone formation and bone resorption, this latter function after its binding to the calcitonin ...
Rachel A. Davey   +33 more
core   +1 more source

Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors

open access: yesNature Communications
Obesity is a major and increasingly prevalent chronic metabolic disease with numerous comorbidities. While recent incretin-based therapies have provided pharmaceutical inroads into treatment of obesity, there remains an ongoing need for additional ...
Jianjun Cao   +14 more
doaj   +1 more source

Structural Analysis of Amylin and Amyloid β Peptide Signaling in Alzheimer’s Disease

open access: yesBiomolecules
Amylin and amyloid β belong to the same protein family and activate the same receptors. Amyloid β levels are elevated in Alzheimer’s disease. Recent studies have demonstrated that amylin-based peptides can reduce the symptoms of Alzheimer’s disease in ...
Longsheng Xie   +4 more
doaj   +1 more source

Genetics‐Informed Pharmacological Intervention in Gestational Diabetes Mellitus: Current Therapeutic Alignment, Emerging Targets and a Translational Roadmap

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Gestational diabetes mellitus (GDM) complicates roughly one in seven pregnancies and predicts later maternal type 2 diabetes mellitus (T2DM). Yet its pharmacological management still rests on a handful of agents (insulin, metformin and glibenclamide), none of them selected on the basis of the disease's molecular genetics.
Wael Osman
wiley   +1 more source

Home - About - Disclaimer - Privacy